deltatrials
Active Not Recruiting INTERVENTIONAL NCT05733208

The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery

The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery in Patients at a High Risk of Cardiac Events

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University

Updated 8 times since 2023 Last updated: Apr 21, 2026 Started: May 6, 2023 Primary completion: Jul 2, 2024 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Myocardial Injury and Non-cardiac Surgery, this trial is ongoing. The trial is conducted by Sixth Affiliated Hospital, Sun Yat-sen University and has accumulated 8 data snapshots since 2023. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Study Description(click to expand)

This is a multicentre, randomised, sham-controlled, observer blinded trial. Patients at high clinical risk for cardiovascular events and scheduled to undergo major abdominal surgery will be enrolled. A total of 766 patients are randomised (1:1 ratio) to receive RIPC or no RIPC (control) before anaesthesia induction. RIPC will comprise four alternating cycles of cuff inflation for 5 min to 200 mm Hg and deflation for 5 min. In controls, the identical looking cuff will be placed around the arm but not actually inflated for 40 minutes. The primary outcome was myocardial injury after surgery within three days of surgery. The secondary outcomes were peak plasma hs-cTnT and total hs-cTnT release during the first three days after surgery, hs-cTnT above the prognostically important thresholds, length of hospital stay after surgery, and length of stay in the intensive care unit, myocardial infarction, major adverse cardiovascular events, cardiac-related death and all cause death within 30 days, 6 months, 1 year and 2 years after surgery, postoperative morbidity and adverse events within 30 days after surgery. Besides, blood samples were stored for the other ancillary studies.

This is a multicentre, randomised, sham-controlled, observer blinded trial. Patients at high clinical risk for cardiovascular events and scheduled to undergo major abdominal surgery will be enrolled. A total of 766 patients are randomised (1:1 ratio) to receive RIPC or no RIPC (control) before anaesthesia induction. RIPC will comprise four alternating cycles of cuff inflation for 5 min to 200 mm Hg and deflation for 5 min. In controls, the identical looking cuff will be placed around the arm but not actually inflated for 40 minutes. The primary outcome was myocardial injury after surgery within three days of surgery. The secondary outcomes were peak plasma hs-cTnT and total hs-cTnT release during the first three days after surgery, hs-cTnT above the prognostically important thresholds, length of hospital stay after surgery, and length of stay in the intensive care unit, myocardial infarction, major adverse cardiovascular events, cardiac-related death and all cause death within 30 days, 6 months, 1 year and 2 years after surgery, postoperative morbidity and adverse events within 30 days after surgery. Besides, blood samples were stored for the other ancillary studies.

Status Flow

~Mar 2023 – ~Jun 2023 · 3 months · monthly snapshotNot Yet Recruiting~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshotNot Yet Recruiting~Jul 2023 – ~Mar 2024 · 8 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshotRecruiting~Jan 2025 – ~Apr 2026 · 16 months · monthly snapshotActive Not RecruitingApr 23, 2026 – present · 4 months · daily APIActive Not Recruiting

Change History

8 versions recorded
  1. Apr 23, 2026 — Present [daily]

    Active Not Recruiting

    Phase: NANone

  2. Jan 2025 — Apr 2026 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  3. Sep 2024 — Jan 2025 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Mar 2024 — Jul 2024 [monthly]

    Recruiting NA

Show 3 earlier versions
  1. Jul 2023 — Mar 2024 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  2. Jun 2023 — Jul 2023 [monthly]

    Not Yet Recruiting NA

  3. Mar 2023 — Jun 2023 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

This is a multicentre, parallel-group, randomised, sham-controlled, observer blinded trial, assessing the efficacy of remote ischemic preconditioning on preventing myocardial injury after noncardiac surgery.

Contact Information

Sponsor contact:
  • Sixth Affiliated Hospital, Sun Yat-sen University
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations